Clinical Trial Update: STAAR-2 Clinical Study [Phase 4]

View source ↗

Summary

Amgen's STAAR-2 Phase 4 clinical study in chronic kidney disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Snippet

Sponsor: Amgen | Conditions: Chronic Kidney Disease, Chronic Renal Insufficiency | Phase 4 | Status: COMPLETED